1.Fabrication of Functional Cell Sheets with Human Thyrocytes from Non-Tumorous Thyroid Tissue
Yu HUANG ; Kosho YAMANOUCHI ; Yusuke SAKAI ; Sayaka KUBA ; Chika SAKIMURA ; Michi MORITA ; Kengo KANETAKA ; Mitsuhisa TAKATSUKI ; Susumu EGUCHI
Tissue Engineering and Regenerative Medicine 2019;16(5):491-499
BACKGROUND: Engineered cell sheet transplantation has been considered an alternative physiological therapy for endocrine disorders. In this study, we attempted to fabricate functional human thyroid cell sheets using the engineering technology by culturing primary thyrocytes in free-feeder monolayers and assessed their proliferation and function in two different media. METHODS: The non-tumorous tissues (approximately 2 g) were dissected during surgery. Primary human thyroid cells were isolated by mechanical dispersion and treatment with isolation solution. The cells were cultured on tissue culture dishes or temperature-responsive culture dishes to induce the formation of detached cell sheets. RESULTS: Primary thyroid cells isolated from nine patients were positive for thyroid transcription factor 1, thyroglobulin (TG) and cytokeratin 7. Cell sheets with follicles were fabricated by cells incubated in both Dulbecco's Modified Eagle Medium (DMEM) and hepatocyte-defined medium (HDM) culture medium. The diameter and thickness of sheets fabricated in HDM were larger and thicker than those fabricated from DMEM. Furthermore, the cells incubated in HDM secreted higher levels of fT3 and fT4 than those incubated in DMEM. The thyroid peroxidase and TG mRNA of cells maintained in HDM were higher than those in cells maintained in DMEM. CONCLUSION: HDM appears suitable as a culture medium for maintaining primary thyrocytes and fabricating functional cell sheets. These in vitro findings may contribute to the development of appropriate culture conditions for human thyrocytes as well as engineered functional cell sheets.
Eagles
;
Humans
;
In Vitro Techniques
;
Iodide Peroxidase
;
Keratin-7
;
RNA, Messenger
;
Thyroglobulin
;
Thyroid Gland
;
Transcription Factors
2.Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy:A Case Report
Yuki HARA ; Rin YAMAGUCHI ; Ryota OTSUBO ; Ayako FUKUSHIMA ; Eiko INAMASU ; Momoko AKASHI ; Michi MORITA ; Sayaka KUBA ; Susumu EGUCHI ; Keitaro MATSUMOTO
Journal of Breast Cancer 2024;27(5):343-349
Phyllodes tumors (PT) are fibroepithelial neoplasms that are treated by complete surgical excision. The effectiveness of adjuvant therapies, including radiotherapy and chemotherapy, for PT remains unclear, and the use of neoadjuvant chemotherapy (NAC) is yet to be established. We report a case of a 15-year-old girl with acute lymphatic leukemia (ALL) who was incidentally diagnosed with a 50-mm borderline PT in the left breast using computed tomography, ultrasonography, and histological examination following needle biopsy. Lumpectomy was performed after administration of anthracycline-based chemotherapy for ALL, resulting in tumor size reduction. Histopathological examination of the excised specimen demonstrated decreased mitotic activity and stromal cellularity post-chemotherapy. To our knowledge, this is the first study to report the histopathological differences in pre- and post-chemotherapy borderline PT samples. Our findings suggest that NAC may induce changes in borderline PT, potentially affecting diagnosis and treatment decisions. Hence, further investigation is warranted in this regard.
3.Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy:A Case Report
Yuki HARA ; Rin YAMAGUCHI ; Ryota OTSUBO ; Ayako FUKUSHIMA ; Eiko INAMASU ; Momoko AKASHI ; Michi MORITA ; Sayaka KUBA ; Susumu EGUCHI ; Keitaro MATSUMOTO
Journal of Breast Cancer 2024;27(5):343-349
Phyllodes tumors (PT) are fibroepithelial neoplasms that are treated by complete surgical excision. The effectiveness of adjuvant therapies, including radiotherapy and chemotherapy, for PT remains unclear, and the use of neoadjuvant chemotherapy (NAC) is yet to be established. We report a case of a 15-year-old girl with acute lymphatic leukemia (ALL) who was incidentally diagnosed with a 50-mm borderline PT in the left breast using computed tomography, ultrasonography, and histological examination following needle biopsy. Lumpectomy was performed after administration of anthracycline-based chemotherapy for ALL, resulting in tumor size reduction. Histopathological examination of the excised specimen demonstrated decreased mitotic activity and stromal cellularity post-chemotherapy. To our knowledge, this is the first study to report the histopathological differences in pre- and post-chemotherapy borderline PT samples. Our findings suggest that NAC may induce changes in borderline PT, potentially affecting diagnosis and treatment decisions. Hence, further investigation is warranted in this regard.
4.Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy:A Case Report
Yuki HARA ; Rin YAMAGUCHI ; Ryota OTSUBO ; Ayako FUKUSHIMA ; Eiko INAMASU ; Momoko AKASHI ; Michi MORITA ; Sayaka KUBA ; Susumu EGUCHI ; Keitaro MATSUMOTO
Journal of Breast Cancer 2024;27(5):343-349
Phyllodes tumors (PT) are fibroepithelial neoplasms that are treated by complete surgical excision. The effectiveness of adjuvant therapies, including radiotherapy and chemotherapy, for PT remains unclear, and the use of neoadjuvant chemotherapy (NAC) is yet to be established. We report a case of a 15-year-old girl with acute lymphatic leukemia (ALL) who was incidentally diagnosed with a 50-mm borderline PT in the left breast using computed tomography, ultrasonography, and histological examination following needle biopsy. Lumpectomy was performed after administration of anthracycline-based chemotherapy for ALL, resulting in tumor size reduction. Histopathological examination of the excised specimen demonstrated decreased mitotic activity and stromal cellularity post-chemotherapy. To our knowledge, this is the first study to report the histopathological differences in pre- and post-chemotherapy borderline PT samples. Our findings suggest that NAC may induce changes in borderline PT, potentially affecting diagnosis and treatment decisions. Hence, further investigation is warranted in this regard.